Skip to main content
OpenTrials
Completed

NCT Number: NCT01606280

Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

This study examines the value of stem cell transplantation in managing light chain amyloidisis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Amyloidosis Metabolic Diseases Nutritional and Metabolic Diseases Proteostasis Deficiencies

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

About this study

  • How does age at diagnosis affect prognosis in primary amyloidosis?
  • How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
  • How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis?
  • How does initial treatment affect prognosis in primary amyloidosis?
  • How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible for Stem cell transplantation less than age 75

Exclusion criteria

  • Creatinine > 3.0
  • BNP > 10000

Treatment and study plan

Primary outcomes

  1. Survival

    Time frame: up to 8 years

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Reporting of Amyloidosis Stem Cell Transplantation Outcomes

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
May 25, 2012
Registry last updated
Jan 22, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.